In a Winners Podcast episode, Faruk Capan, Chief Innovation Officer at EVERSANA, discusses how AI can transform pharmaceutical marketing — without compromising compliance.
Pharmaceutical marketing operates under constraints most industries never face. Every claim must be compliant, every message approved, and every patient interaction carefully vetted. Historically, that reality has meant campaigns taking four to six months to reach market, often involving 50–60 people across medical, regulatory, creative, and technical teams.
This conversation builds on EVERSANA’s recent recognition by the Business Intelligence Group, where the AI Agency Platform was named an AI Excellence Award winner in the Agentic AI category — acknowledging a model designed to orchestrate AI and human expertise at scale in highly regulated environments.
Compliance Shapes Everything
With more than 30 years in pharmaceutical advertising, Capan describes AI as the most accelerated and complex transformation he’s seen in healthcare. While compliance requirements exist to protect patients, they also introduce friction that compounds across every step of commercialization. Research shows that review and approval processes can account for 30–40% of total campaign development time.
EVERSANA’s challenge was clear: compress timelines without compromising regulatory safeguards or trust.
A Startup Inside the Enterprise
Rather than attempting incremental change across a large organization, EVERSANA built a dedicated team and challenged them to start from scratch. The group operated like a startup, with full accountability for development, commercialization, and adoption.
Within nine months, the platform engaged 165 prospective clients, with 10–15 already piloting or actively using it. The constraint quickly became onboarding capacity — not demand.
The 80/20 Model
At the core of this transformation is EVERSANA’s 80/20 model:
- 80% AI execution for speed, scale, and efficiency
- 20% human expertise for judgment, compliance, and high‑value decisions
Instead of dozens of people touching each project, engagements now involve 5–10 highly skilled experts guiding the AI across medical, regulatory, creative, and strategic domains.
Built‑In Compliance and Speed
Developed in partnership with Google Cloud, the AI Agency Platform embeds compliance checks throughout the workflow rather than at the end. Claims, references, and balance are validated continuously, enabling faster approvals and significantly less rework.
The impact is substantial: projects that once took months can now be completed in weeks, with 2–3x speed improvements and ~30% cost savings. The model also enables true personalization — scaling from a few templates to dozens of compliant, tailored messages.
Lessons for Innovation Leaders
Capan closes with a broader insight: in AI, speed is the real competitive advantage. Ideas can be copied quickly, but execution, adoption, and continuous improvement determine who wins.
For EVERSANA, the goal isn’t replacing humans: it’s removing friction so experts can focus where they matter most.
Learn more about EVERSANA’s AI Agency Platform
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…